| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Bolt Biotherapeutics, Inc.
13G/A
BOLT · 097702203
|
3.8% |
2/13/2026
Event 12/31/2025
|
||||
| Vivo Capital Fund VIII, L.P. | 0% | |||||
| Vivo Capital Surplus Fund VIII, L.P. | 0% | |||||
| Vivo Capital VIII, LLC | 0% | |||||
| Vivo Panda Fund, L.P. | 3.8% | |||||
| Vivo Panda, LLC | 3.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.